［1］Van Meer G.The different hues of lipid rafts［J］.Science，2002，296(5569)：855-857.
［2］Simons K，Toomre D.Lipid rafts and signal transduction［J］.Nat Rev Mol Cell Biol，2000，1(1)：31-39.
［3］Zajchowski LD，Robbins SM.Lipid rafts and little cavescompartmentalized signalling in membrane microdomains［J］.Eur J Biochem，2002，269：737-752.
［4］Langhorst MF，Reuter A，Jaeger FA，et al.Trafficking of the microdomain scaffolding protein reggie-1/flotillin-2［J］.Eur J Cell Biol，2008，87(4)：211-226.
［5］Bickel PE，Scherer PE，Schnitzer JE，et al.Flotillin and epidermal surface antigen define a new family of caveolae-associated integral membrane proteins［J］.J Biol Chem，1997，272(21)：13793-13802.
［6］Neumann-Giesen C，Fernow I，Amaddii M，et al.Role of EGF-induced tyrosine phosphorylation of reggie-1/flotillin-2 in cell spreading and signaling to the actin cytoskeleton［J］.J Cell Sci 2007，120(3)：395-406.
［7］Stuermer CA，Langhorst MF，Wiechers MF，et al.PrPc capping in T cells promotes its association with the lipid raft proteins reggie-1 and reggie-2 and leads to signal transduction［J］.FASEB J，2004，18(14)：1731-1733.
［8］Munro S.Lipid rafts elusive or illusive［J］? Cell，2003，115(3)：377-388.
［9］Hazarika P，Dham N，Patel P，et al.Flotillin 2 is distinct from epidermal surface antigen (ESA) and is associated with filopodia formation［J］.J Cell Biochem，1999，75(1)：147-159.
［10］Langhorst MF，Solis GP，Hannbeck S，et al.Linking membrane microdomains to the cytoskeleton：regulation of the lateral mobility of reggie-1/flotillin-2 by interaction with actin［J］.FEBS Lett，2007，581(24)：4697-4703.
［11］Zhao L，Lin L，Pan C，et al.Flotillin-2 promotes nasopharyngeal carcinoma metastasis and is necessary for the epithelial-mesenchymal transition induced by transforming growth factor-β［J］.Oncotarget，2015，6(12)：9781-9793.
［12］Zhang LH.A preliminary study of the expression and mechanism of Flotillin-2 in nasopharyngeal carcinoma［D］.Changsha:Central South University，2012.［张立华.Flotillin-2在鼻咽癌中的表达及作用机制的初步探索［D］.长沙：中南大学，2012.］
［13］Liu J，Huang W，Ren CP，et al.Flotillin-2 promotes metastasis of nasopharyngeal carcinoma by activating NF-kappaB and PI3K/Akt3 signaling pathways［J］.Sci Rep，2015，5：11614.
［14］Berger T，Ueda T，Arpaia E，et al.Flotillin-2 deficiency leads to reduced lung metastases in a mouse breast cancer model［J］.Oncogene，2013，32(41)：4989-4994.
［15］Xie G，Li J，Chen J，et al.Knockdown of Flot2 impairs the proliferation of breast cancer cells through modulation of Akt/FOXO signaling［J］.Oncol Rep，2015，33(5)：2285-2290.
［16］Wang YL，Yao WJ，Guo L，et al.Expression of flotillin-2 in human non-small cell lung cancer and its correlation with tumor progression and patient survival［J］.Int J Clin Exp Pathol，2015，8(1)：601-607.
［17］Mou X，Liu S.miR-485 inhibits metastasis and EMT of lung adenocarcinoma by targeting Flot2［J］.Biochem Biophys Res Commun，2016，477(4)：521-526.
［18］Cao K，Xie D，Cao P，et al.SiRNA-mediated flotillin-2 (Flot2) downregulation inhibits cell proliferation，migration，and invasion in gastric carcinoma cells［J］.Oncol Res，2014，21(5)：271-279.
［19］Li Q，Peng J，Li X，et al.miR-449a targets Flot2 and inhibits gastric cancer invasion by inhibiting TGF-β-mediated EMT［J］.Diagn Pathol，2015，10：202.
［20］Yan Y，Yang FQ，Zhang HM，et al.Up-regulation of Flot2 is associated with renal cell carcinoma progression［J］.Tumour Biol，2014，35(10)：10479-10486.
［21］Xu Hongli，Hu Ping，Zhang Zhen，et al.Effect of silence of FLOT2 expression by siRNA on proliferation of human renal cell carcinoma cells［J］.Modern Oncology，2015，23(23)：3376-3379.［许洪礼，胡萍，张振，等.siRNA干扰FLOT2基因表达对肾细胞癌细胞增殖的影响［J］.现代肿瘤医学，2015，23(23)：3376-3379.］
［22］Liu YQ，Lin Li，Huang ZJ，et al.High expression of flotillin-2 is associated with poor clinical survival in cervical carcinoma［J］.Int J Clin Exp Pathol，2015，8(1)：622-628.
［23］Hazarika P，McCarty MF，Prieto VG，et al.Up-regulation of Flotillin-2 is associated with melanoma progression and modulates expression of the thrombin receptor protease activated receptor 1［J］.Cancer Res，2004，64(20)：7361-7369.
［24］Liu R，Xie H，Luo C，et al.Identification of FLOT2 as a novel target for microRNA-34a in melanoma［J］.J Cancer Res Clin Oncol，2015，141(6)：993-1006.
［25］Sasaki Y，Oshima Y，Koyama R，et al.Identification of flotillin-2，a major protein on lipid rafts，as a novel target of p53 family members［J］.Mol Cancer Res，2008，6(3)：395-406.